NEOS Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Buy
35,545
+4,363
+14% +$1.62M 0.05% 224
2026
Q1
$9.13M Sell
31,182
-2,422
-7% -$796K 0.05% 255
2025
Q4
$11.8M Buy
33,604
+4,633
+16% +$1.57M 0.07% 206
2025
Q3
$9.36M Buy
28,971
+9,101
+46% +$2.83M 0.07% 209
2025
Q2
$7.73M Buy
19,870
+6,183
+45% +$2.49M 0.1% 177
2025
Q1
$5.95M Buy
13,687
+2,504
+22% +$1.01M 0.11% 174
2024
Q4
$4.13M Buy
11,183
+2,483
+29% +$1.04M 0.1% 191
2024
Q3
$4.52M Buy
8,700
+1,624
+23% +$868K 0.14% 141
2024
Q2
$3.83M Buy
7,076
+1,992
+39% +$1.05M 0.16% 121
2024
Q1
$2.64M Buy
5,084
+1,824
+56% +$907K 0.16% 119
2023
Q4
$1.54M Buy
3,260
+1,013
+45% +$468K 0.15% 140
2023
Q3
$978K Buy
+2,247
New +$1.02M 0.13% 150

Other funds holding ELV

NEOS Investment Management's ELV Position: Q2 2026 in Review

NEOS Investment Management increased its Elevance Health (ELV) stake by 14% in Q2 2026, buying an estimated $1.62M and bringing the position to 35,545 shares worth $13.7M. The position accounts for 0.05% of the portfolio, ranked #224.

NEOS Investment Management first reported a position in ELV in Q3 2023 and has held it in 12 quarters since. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • NEOS Investment Management held 35,545 shares of Elevance Health worth $13.7M as of Q2 2026.
  • NEOS Investment Management bought 4,363 Elevance Health shares in Q2 2026, an estimated $1.62M.
  • Elevance Health made up 0.05% of NEOS Investment Management's portfolio in Q2 2026, its #224 holding.
  • NEOS Investment Management first reported a position in Elevance Health in Q3 2023 and has held it in 12 quarters since.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.